<DOC>
	<DOCNO>NCT00225199</DOCNO>
	<brief_summary>The purpose study demonstrate safety efficacy SH T00660AA compare placebo treatment endometriosis</brief_summary>
	<brief_title>Efficacy Safety SH T00660AA Treatment Endometriosis</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany . Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<criteria>Female patient endometriosisassociated pelvic pain Pregnant lactate woman history suspicion hormone dependent tumor therapy resistant endometriosis need primary surgical treatment condition forbid participation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>